August 18, 2026 10:52 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
BJP reshuffles top organisation seven months after Nitin Nabin's elevation | West Bengal STF arrests suspected aide of ISI 'agent' Rana Rauf in Kolkata | ‘Very hopeful’: Indian envoy Dinesh Trivedi breaks silence on PM Tarique Rahman’s proposed India visit | Shehzad Poonawalla doubles down on BJP exit, urges party to accept resignation | Tarapith tragedy: Seven pilgrims killed as hotel goes up in flames before dawn | Bengal STF nabs suspected aide of ISI 'agent' Rana Rauf in Kolkata | After SC rebuke, BCI chief apologises to NALSAR students over enrolment freeze row | Independence Day: PM Modi’s big youth pitch— AI training, free coaching amid exam row and job concerns | ‘Shakti Ki Saptadhara’: Modi reveals 7 pillars to power India’s next leap in his I-Day speech from Red Fort | West Bengal STF arrests 3 more suspected Pakistani spies in Cooch Behar

Aarti Industries Q1FY16 Net Profit at Rs. 60.90 crores

| | Aug 07, 2015, at 08:16 pm
Mumbai, Aug 7 (IBNS): Aarti Industries Limited (AIL), a leading and highly integrated chemical manufacturer company involved in manufacturing of various benzene based downstream and derivative products, has declared its financial results for the first quarter ended June 30, 2015.

Total Income for the quarter ended June 30, 2015 stood at Rs. 683.07 crores. Inspite of the increase in volumes by about 14% YoY, the fall in RM prices, trailing lower crude prices, resulted into reduction of total income.

EBITDA for the quarter stood at Rs. 131.91 crores compared to Rs. 113.09 crores in Q1FY15, an increase of 16.6% YoY.

Comparing on yearly basis, Net Profit of the company increased by about 47% to Rs. 60.90 crores in Q1FY16 as against Rs. 41.43 crores registered during Q1FY15.

The Company had part-commissioned its scale up of PDA capacities, i.e, from 250 tpm to about 450 tpm in Q1FY16 and targets to scale it up to about 1000 tpm by the end of current financial year. The Company also expects to commission the second phase of its NCB expansion, thereby scaling it up from 57000 tpa (a year back) to 75000 tpa, by the end of Q2FY16.


Further, the recently concluded USFDA Inspection had been favorable for the company. This would facilitate and expedite faster approvals for various APIs in pipeline, thereby increasing the presence in the Regulated markets.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.